Adebrelimab + Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC
Adebrelimab + Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC
Not yet recruiting · NCT07035392 · Registry updated 2025-06-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Adebrelimab + Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC | non-small cell lung carcinoma | Not yet recruiting | Phase 2 | 2025-06-25 | NCT07035392 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Zhangzhou Municipal Hospital | 4 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||